Retinoic Acid Receptor β2 (RARb2): Nonivasive Biomarker for Distinguishing Malignant versus Benign Prostate Lesions from Bodily Fluids

  1. Home
  2. Articles

Retinoic Acid Receptor β2 (RARb2): Nonivasive Biomarker for Distinguishing Malignant versus Benign Prostate Lesions from Bodily Fluids

R. Dumache, M. Puiu, R. Minciu, R. Bardan, D. David, A. Tudor, B. Bumbãcilã
Original article, no. 6, 2012